Related references
Note: Only part of the references are listed.Automatic segmentation of the thalamus using a massively trained 3D convolutional neural network: higher sensitivity for the detection of reduced thalamus volume by improved inter-scanner stability
Roland Opfer et al.
EUROPEAN RADIOLOGY (2023)
Infratentorial lesions in multiple sclerosis patients: intra- and inter-rater variability in comparison to a fully automated segmentation using 3D convolutional neural networks
Julia Krueger et al.
EUROPEAN RADIOLOGY (2022)
Faster and Better: How Anomaly Detection Can Accelerate and Improve Reporting of Head Computed Tomography
Tom Finck et al.
DIAGNOSTICS (2022)
Joint MRI T1 Unenhancing and Contrast-enhancing Multiple Sclerosis Lesion Segmentation with Deep Learning in OPERA Trials
Anitha Priya Krishnan et al.
RADIOLOGY (2022)
Deep learning-based acceleration of Compressed Sense MR imaging of the ankle
Sarah C. Foreman et al.
EUROPEAN RADIOLOGY (2022)
Deep learning segmentation of gadolinium-enhancing lesions in multiple sclerosis
Ivan Coronado et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Relaxation-Enhanced Angiography Without Contrast and Triggering (REACT) for Fast Imaging of Extracranial Arteries in Acute Ischemic Stroke at 3T
Lenhard Pennig et al.
CLINICAL NEURORADIOLOGY (2021)
Automatic segmentation of gadolinium-enhancing lesions in multiple sclerosis using deep learning from clinical MRI
Sibaji Gaj et al.
PLOS ONE (2021)
Emerging deep learning techniques using magnetic resonance imaging data applied in multiple sclerosis and clinical isolated syndrome patients (Review)
Eleftherios E. Kontopodis et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Automated volumetric assessment with artificial neural networks might enable a more accurate assessment of disease burden in patients with multiple sclerosis
Gianluca Brugnara et al.
EUROPEAN RADIOLOGY (2020)
Deep Learning for Predicting Enhancing Lesions in Mu pie Sclerosis from Noncontrast MRI
Ponnada A. Narayana et al.
RADIOLOGY (2020)
Reduction of respiratory motion artifacts in gadoxetate-enhanced MR with a deep learning-based filter using convolutional neural network
M. -L. Kromrey et al.
EUROPEAN RADIOLOGY (2020)
Development and clinical application of deep learning model for lung nodules screening on CT images
Sijia Cui et al.
SCIENTIFIC REPORTS (2020)
Review of Deep Learning Approaches for the Segmentation of Multiple Sclerosis Lesions on Brain MRI
Chenyi Zeng et al.
FRONTIERS IN NEUROINFORMATICS (2020)
Fully automated longitudinal segmentation of new or enlarged multiple sclerosis lesions using 3D convolutional neural networks
Julia Krueger et al.
NEUROIMAGE-CLINICAL (2020)
From Compressed-Sensing to Artificial Intelligence-Based Cardiac MRI Reconstruction
Aurelien Bustin et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Mitchell T. Wallin et al.
LANCET NEUROLOGY (2019)
Fully convolutional network ensembles for white matter hyperintensities segmentation in MR images
Hongwei Li et al.
NEUROIMAGE (2018)
Survey of automated multiple sclerosis lesion segmentation techniques on magnetic resonance imaging
Antonios Danelakis et al.
COMPUTERIZED MEDICAL IMAGING AND GRAPHICS (2018)
Artificial intelligence in radiology
Ahmed Hosny et al.
NATURE REVIEWS CANCER (2018)
Dermatologist-level classification of skin cancer with deep neural networks
Andre Esteva et al.
NATURE (2017)
Improving automated multiple sclerosis lesion segmentation with a cascaded 3D convolutional neural network approach
Sergi Valverde et al.
NEUROIMAGE (2017)
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
S. L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
MRI FLAIR lesion segmentation in multiple sclerosis: Does automated segmentation hold up with manual annotation?
Christine Egger et al.
NEUROIMAGE-CLINICAL (2017)
Adaptive multi-level conditional random fields for detection and segmentation of small enhanced pathology in medical images
Zahra Karimaghaloo et al.
MEDICAL IMAGE ANALYSIS (2016)
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study
Ludwig Kappos et al.
JAMA NEUROLOGY (2016)
Quantitative Measurement of tissue damage and recovery within new T2w lesions in pediatric- and adult-onset multiple sclerosis
Rezwan Ghassemi et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Automatic Detection of Gadolinium-Enhancing Multiple Sclerosis Lesions in Brain MRI Using Conditional Random Fields
Zahra Karimaghaloo et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2012)
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Jeffrey A. Cohen et al.
LANCET (2012)
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
Eva Havrdova et al.
LANCET NEUROLOGY (2009)
Segmentation of gadolinium-enhanced lesions on MRI in multiple sclerosis
Sushmita Datta et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2007)
Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials
F Barkhof et al.
NEUROLOGY (2005)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Share Paper
